Profile
Dr. David L.
Deperthes is Vice President-Business Development & Licensing at Debiopharm SA, Founder at Med Discovery SA, and Chief Executive Officer & Director at Debiopharm Diagnostics S.A. He is on the Board of Directors at Debiopharm Diagnostics S.A.
Dr. Deperthes was previously employed as Head-Urology Research Unit by Centre Hospitalier Universitaire Vaudois.
David Luc Deperthes active positions
| Companies | Position | Start |
|---|---|---|
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Corporate Officer/Principal | 2011-12-31 |
Med Discovery SA
Med Discovery SA BiotechnologyHealth Technology Operates as biopharmaceutical company, which develops treatments for cancers | Founder | 2001-12-31 |
Former positions of David Luc Deperthes
| Companies | Position | End |
|---|---|---|
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Acts as an alternative investment manager | Chief Executive Officer | - |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Operates university hospitals | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
Med Discovery SA
Med Discovery SA BiotechnologyHealth Technology Operates as biopharmaceutical company, which develops treatments for cancers | Health Technology |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Operates university hospitals | Health Services |
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Acts as an alternative investment manager | Finance |
- Stock Market
- Insiders
- David Luc Deperthes
















